Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis

被引：1
|
作者：
Wagner, Brandie D. [1 ,2 ,3 ]
Berkalieva, Asem [1 ]
Borges, Monica [1 ]
Fleming, Grant [1 ]
Graham, Noah [1 ]
Peterson, Emily [1 ]
Jin, Xin [1 ]
Zemanick, Edith T. [2 ,3 ]
机构：
[1] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO USA
[3] Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA
来源：
HEALTH SCIENCE REPORTS | 2021年 / 4卷 / 01期
关键词：
BIOMARKERS;
D O I：
10.1002/hsr2.246
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Predictors of pulmonary exacerbation treatment in cystic fibrosis
    Sanders, Don B.
    Ostrenga, Joshua S.
    Rosenfeld, Margaret
    Fink, Aliza K.
    Schechter, Michael S.
    Sawicki, Gregory S.
    Flume, Patrick A.
    Morgan, Wayne J.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 407 - 414
  • [2] PREDICTORS OF PULMONARY EXACERBATION TREATMENT IN CYSTIC FIBROSIS
    Ostrenga, J.
    Sanders, D. B.
    Rosenfeld, M.
    Fink, A.
    Schechter, M. S.
    Sawicki, G. S.
    Flume, P.
    Morgan, W. J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S383 - S383
  • [3] Iron Homeostasis during Cystic Fibrosis Pulmonary Exacerbation
    Gifford, Alex H.
    Moulton, Lisa A.
    Dorman, Dana B.
    Olbina, Gordana
    Westerman, Mark
    Parker, H. Worth
    Stanton, Bruce A.
    O'Toole, George A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2012, 5 (04): : 368 - 373
  • [4] Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
    Wojsyk-Banaszak, I
    Sobkowiak, P.
    Jonczyk-Potoczna, K.
    Narozna, B.
    Langwinski, W.
    Szczepanik, M.
    Kycler, Z.
    Breborowicz, A.
    Szczepankiewicz, A.
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [5] Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment
    Cogen, Jonathan D.
    Sanders, Don B.
    Slaven, James E.
    Faino, Anna V.
    Somayaji, Ranjani
    Gibson, Ron L.
    Hoffman, Lucas R.
    Ren, Clement L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (09) : 1293 - 1298
  • [6] Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation
    Kidd, James M.
    Sakon, Colleen M.
    Oleksiuk, Louise-Marie
    Cies, Jeffrey J.
    Pettit, Rebecca S.
    Nicolau, David P.
    Kuti, Joseph L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
  • [7] Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis
    Carter, Suzanne C.
    Franciosi, Alessandro N.
    O'Shea, Kate M.
    O'Carroll, Orla M.
    Sharma, Ashutosh
    Bell, Aoife
    Keogan, Brian
    O'Reilly, Paul
    Coughlan, Suzie
    Law, Sheonagh M.
    Gray, Robert D.
    Hisert, Katherine B.
    Singh, Pradeep K.
    Cooke, Gordon
    Grogan, Brenda
    De Gascun, Cillian F.
    Gallagher, Charles G.
    Nicholson, Trevor T.
    Quon, Bradley S.
    McKone, Edward F.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (11) : 1818 - 1826
  • [8] USE OF INHALED TOBRAMYCIN FOR TREATMENT OF CYSTIC FIBROSIS PULMONARY EXACERBATION
    Lubsch, L.
    Carlson, A.
    Albers, G.
    Armbrecht, E.
    PEDIATRIC PULMONOLOGY, 2011, : 349 - 349
  • [9] Factors influencing treatment response of pulmonary exacerbation in cystic fibrosis
    Singh, J.
    Robinson, P.
    Pandit, C.
    Kennedy, B.
    Weldon, B.
    Bailey, B.
    John, M.
    Fitzgerald, D.
    Selvadurai, H.
    RESPIROLOGY, 2022, 27 : 189 - 189
  • [10] Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation
    Sc, Noa Nezer M.
    Shoseyov, David
    Kerem, Eitan
    Zangen, David Haim
    JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (03) : 199 - 204
12345